Exact Mass: 606.1737
Exact Mass Matches: 606.1737
Found 27 metabolites which its exact mass value is equals to given mass value 606.1737,
within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error
0.0002 dalton.
Aurasperone B
10-{2,5-dihydroxy-6,8-dimethoxy-2-methyl-4-oxo-2H,3H,4H-naphtho[2,3-b]pyran-7-yl}-2,5-dihydroxy-6,8-dimethoxy-2-methyl-2H,3H,4H-naphtho[2,3-b]pyran-4-one
Aurasperone B is a mycotoxin from Aspergillus niger, Aspergillus awamori and Aspergillus fonsecaeu
4,2,3,4-Tetrahydroxychalcone 4-O-(2-O-acetyl-6-O-cinnamoyl)glucoside
4,2,3,4-Tetrahydroxychalcone 4-O- (2"-O-acetyl-6"-O-cinnamoyl) glucoside
Skullcapflavone I 2-(2-E-cinnamoylglucoside)
5-Hydroxy-7,8-dimethoxy-2-[2-[[2-O-[(2E)-1-oxo-3-phenyl-2-propenyl]-beta-D-glucopyranosyl]oxy]phenyl]-4H-1-benzopyran-4-one
Skullcapflavone I 2-(4-E-Cinnamoylglucoside)
5-Hydroxy-7,8-dimethoxy-2- [ 2- [ [ 4-O- [ (2E) -1-oxo-3-phenyl-2-propenyl ] -beta-D-glucopyranosyl ] oxy ] phenyl ] -4H-1-benzopyran-4-one
skullcapflavone I 2-O-beta-D-(3-E-cinnamoyl)glucopyranoside|SkullcapflavoneI 2-O-??-D-(3-E-cinnamoyl)glucopyranoside
skullcapflavone I 2-O-beta-D-(3-E-cinnamoyl)glucopyranoside|SkullcapflavoneI 2-O-??-D-(3-E-cinnamoyl)glucopyranoside
Aurasperone B
10-{2,5-dihydroxy-6,8-dimethoxy-2-methyl-4-oxo-2H,3H,4H-naphtho[2,3-b]pyran-7-yl}-2,5-dihydroxy-6,8-dimethoxy-2-methyl-2H,3H,4H-naphtho[2,3-b]pyran-4-one
A dimeric naphthopyran with formula C32H30O12, isolated from several Aspergillus species.
10-(2,5-dihydroxy-6,8-dimethoxy-2-methyl-4-oxo-3H-benzo[g]chromen-10-yl)-2,5-dihydroxy-6,8-dimethoxy-2-methyl-3H-benzo[g]chromen-4-one
10-(2,5-dihydroxy-6,8-dimethoxy-2-methyl-4-oxo-3H-benzo[g]chromen-10-yl)-2,5-dihydroxy-6,8-dimethoxy-2-methyl-3H-benzo[g]chromen-4-one
A-317491 (sodium salt hydrate)
A-317491 (sodium salt hydrate)
A-317491 sodium salt hydrate is a potent, selective and non-nucleotide antagonist of P2X3 and P2X2/3 receptors, with Kis of 22, 22, 9, and 92 nM for hP2X3, rP2X3, hP2X2/3, and rP2X2/3, respectively. A-317491 sodium salt hydrate is highly selective (IC50>10 μM) over other P2 receptors and other neurotransmitter receptors, ion channels, and enzymes. A-317491 sodium salt hydrate reduces inflammatory and neuropathic pain by blocking P2X3 and P2X2/3 receptor-mediated calcium flux[1][2].
4,5-dihydroxy-6-[2-(5-hydroxy-7,8-dimethoxy-4-oxochromen-2-yl)phenoxy]-2-(hydroxymethyl)oxan-3-yl 3-phenylprop-2-enoate
4,5-dihydroxy-6-[2-(5-hydroxy-7,8-dimethoxy-4-oxochromen-2-yl)phenoxy]-2-(hydroxymethyl)oxan-3-yl 3-phenylprop-2-enoate
methyl 11,16,18,23-tetrahydroxy-7-(1-hydroxy-4-methoxy-4-oxobutyl)-20-methyl-9,14-dioxo-6-oxahexacyclo[11.10.2.0¹,¹⁵.0³,¹².0⁵,¹⁰.0¹⁷,²²]pentacosa-3,5(10),11,15,17,19,21,24-octaene-7-carboxylate
methyl 11,16,18,23-tetrahydroxy-7-(1-hydroxy-4-methoxy-4-oxobutyl)-20-methyl-9,14-dioxo-6-oxahexacyclo[11.10.2.0¹,¹⁵.0³,¹².0⁵,¹⁰.0¹⁷,²²]pentacosa-3,5(10),11,15,17,19,21,24-octaene-7-carboxylate
(2r,3s,4r,5r,6s)-4,5-dihydroxy-2-[2-(5-hydroxy-7,8-dimethoxy-4-oxochromen-2-yl)phenoxy]-6-(hydroxymethyl)oxan-3-yl (2e)-3-phenylprop-2-enoate
(2r,3s,4r,5r,6s)-4,5-dihydroxy-2-[2-(5-hydroxy-7,8-dimethoxy-4-oxochromen-2-yl)phenoxy]-6-(hydroxymethyl)oxan-3-yl (2e)-3-phenylprop-2-enoate
[(2r,3s,4s,5r,6s)-5-(acetyloxy)-6-{2,3-dihydroxy-4-[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]phenoxy}-3,4-dihydroxyoxan-2-yl]methyl (2e)-3-phenylprop-2-enoate
[(2r,3s,4s,5r,6s)-5-(acetyloxy)-6-{2,3-dihydroxy-4-[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]phenoxy}-3,4-dihydroxyoxan-2-yl]methyl (2e)-3-phenylprop-2-enoate
methyl (1r,7s,13s,23s)-11,16,18,23-tetrahydroxy-7-[(1s)-1-hydroxy-4-methoxy-4-oxobutyl]-20-methyl-9,14-dioxo-6-oxahexacyclo[11.10.2.0¹,¹⁵.0³,¹².0⁵,¹⁰.0¹⁷,²²]pentacosa-3,5(10),11,15,17,19,21,24-octaene-7-carboxylate
methyl (1r,7s,13s,23s)-11,16,18,23-tetrahydroxy-7-[(1s)-1-hydroxy-4-methoxy-4-oxobutyl]-20-methyl-9,14-dioxo-6-oxahexacyclo[11.10.2.0¹,¹⁵.0³,¹².0⁵,¹⁰.0¹⁷,²²]pentacosa-3,5(10),11,15,17,19,21,24-octaene-7-carboxylate
6-{2,5-dihydroxy-8,10-dimethoxy-2-methyl-4-oxo-3h-naphtho[1,2-b]pyran-9-yl}-2,5-dihydroxy-8,10-dimethoxy-2-methyl-3h-naphtho[1,2-b]pyran-4-one
6-{2,5-dihydroxy-8,10-dimethoxy-2-methyl-4-oxo-3h-naphtho[1,2-b]pyran-9-yl}-2,5-dihydroxy-8,10-dimethoxy-2-methyl-3h-naphtho[1,2-b]pyran-4-one
[5-(acetyloxy)-6-{2,3-dihydroxy-4-[3-(4-hydroxyphenyl)prop-2-enoyl]phenoxy}-3,4-dihydroxyoxan-2-yl]methyl 3-phenylprop-2-enoate
[5-(acetyloxy)-6-{2,3-dihydroxy-4-[3-(4-hydroxyphenyl)prop-2-enoyl]phenoxy}-3,4-dihydroxyoxan-2-yl]methyl 3-phenylprop-2-enoate
3,5-dihydroxy-2-[2-(5-hydroxy-7,8-dimethoxy-4-oxochromen-2-yl)phenoxy]-6-(hydroxymethyl)oxan-4-yl 3-phenylprop-2-enoate
3,5-dihydroxy-2-[2-(5-hydroxy-7,8-dimethoxy-4-oxochromen-2-yl)phenoxy]-6-(hydroxymethyl)oxan-4-yl 3-phenylprop-2-enoate
(2s,3r,4s,5s,6r)-4,5-dihydroxy-2-[2-(5-hydroxy-7,8-dimethoxy-4-oxochromen-2-yl)phenoxy]-6-(hydroxymethyl)oxan-3-yl (2e)-3-phenylprop-2-enoate
(2s,3r,4s,5s,6r)-4,5-dihydroxy-2-[2-(5-hydroxy-7,8-dimethoxy-4-oxochromen-2-yl)phenoxy]-6-(hydroxymethyl)oxan-3-yl (2e)-3-phenylprop-2-enoate
(2s)-10-[(2r)-2,5-dihydroxy-6,8-dimethoxy-2-methyl-4-oxo-3h-naphtho[2,3-b]pyran-7-yl]-2,5-dihydroxy-6,8-dimethoxy-2-methyl-3h-naphtho[2,3-b]pyran-4-one
(2s)-10-[(2r)-2,5-dihydroxy-6,8-dimethoxy-2-methyl-4-oxo-3h-naphtho[2,3-b]pyran-7-yl]-2,5-dihydroxy-6,8-dimethoxy-2-methyl-3h-naphtho[2,3-b]pyran-4-one
methyl (1r,7r,13s,23s)-11,16,18,23-tetrahydroxy-7-[(1s)-1-hydroxy-4-methoxy-4-oxobutyl]-20-methyl-9,14-dioxo-6-oxahexacyclo[11.10.2.0¹,¹⁵.0³,¹².0⁵,¹⁰.0¹⁷,²²]pentacosa-3,5(10),11,15,17,19,21,24-octaene-7-carboxylate
methyl (1r,7r,13s,23s)-11,16,18,23-tetrahydroxy-7-[(1s)-1-hydroxy-4-methoxy-4-oxobutyl]-20-methyl-9,14-dioxo-6-oxahexacyclo[11.10.2.0¹,¹⁵.0³,¹².0⁵,¹⁰.0¹⁷,²²]pentacosa-3,5(10),11,15,17,19,21,24-octaene-7-carboxylate
(2r,3s,4r,5r,6s)-4,5-dihydroxy-6-[2-(5-hydroxy-7,8-dimethoxy-4-oxochromen-2-yl)phenoxy]-2-(hydroxymethyl)oxan-3-yl (2e)-3-phenylprop-2-enoate
(2r,3s,4r,5r,6s)-4,5-dihydroxy-6-[2-(5-hydroxy-7,8-dimethoxy-4-oxochromen-2-yl)phenoxy]-2-(hydroxymethyl)oxan-3-yl (2e)-3-phenylprop-2-enoate
(6r,6's,7s,7'r)-1',4,6,6',7,7'-hexahydroxy-2,3'-dimethoxy-6',7-dimethyl-5h,5'h,6h,7'h,8h,8'h-[1,2'-bianthracene]-9,9',10,10'-tetrone
(6r,6's,7s,7'r)-1',4,6,6',7,7'-hexahydroxy-2,3'-dimethoxy-6',7-dimethyl-5h,5'h,6h,7'h,8h,8'h-[1,2'-bianthracene]-9,9',10,10'-tetrone
4,5-dihydroxy-2-[2-(5-hydroxy-7,8-dimethoxy-4-oxochromen-2-yl)phenoxy]-6-(hydroxymethyl)oxan-3-yl 3-phenylprop-2-enoate
4,5-dihydroxy-2-[2-(5-hydroxy-7,8-dimethoxy-4-oxochromen-2-yl)phenoxy]-6-(hydroxymethyl)oxan-3-yl 3-phenylprop-2-enoate
(2s,3s,4r,5r,6s)-4,5-dihydroxy-6-[2-(5-hydroxy-7,8-dimethoxy-4-oxochromen-2-yl)phenoxy]-2-(hydroxymethyl)oxan-3-yl (2e)-3-phenylprop-2-enoate
(2s,3s,4r,5r,6s)-4,5-dihydroxy-6-[2-(5-hydroxy-7,8-dimethoxy-4-oxochromen-2-yl)phenoxy]-2-(hydroxymethyl)oxan-3-yl (2e)-3-phenylprop-2-enoate
5'-{7-carboxy-7-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-3-formyl-8-hydroxybicyclo[3.3.1]non-3-en-1-yl}-5-hydroxy-3-oxospiro[1-benzofuran-2,1'-cyclopentane]-2'-carboxylic acid
5'-{7-carboxy-7-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-3-formyl-8-hydroxybicyclo[3.3.1]non-3-en-1-yl}-5-hydroxy-3-oxospiro[1-benzofuran-2,1'-cyclopentane]-2'-carboxylic acid
(2s,3r,4s,5r,6r)-3,5-dihydroxy-2-[2-(5-hydroxy-7,8-dimethoxy-4-oxochromen-2-yl)phenoxy]-6-(hydroxymethyl)oxan-4-yl (2e)-3-phenylprop-2-enoate
(2s,3r,4s,5r,6r)-3,5-dihydroxy-2-[2-(5-hydroxy-7,8-dimethoxy-4-oxochromen-2-yl)phenoxy]-6-(hydroxymethyl)oxan-4-yl (2e)-3-phenylprop-2-enoate
